These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 2581531

  • 1. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ, Logue M, Growdon JH.
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 3. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM, Faull KF, Barchas JD, Berger PA.
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [Abstract] [Full Text] [Related]

  • 4. CSF monoamine metabolites in mania.
    Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW.
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [Abstract] [Full Text] [Related]

  • 5. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC, Wode-Helgodt B.
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [Abstract] [Full Text] [Related]

  • 6. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 7. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H, Nyman H, Schalling D.
    Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
    [Abstract] [Full Text] [Related]

  • 9. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ, Stanley M, Neophytides A, de Leon MJ, Ferris SH, Gershon S.
    Neurobiol Aging; 1981 Dec; 2(1):57-60. PubMed ID: 7266742
    [Abstract] [Full Text] [Related]

  • 10. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Dec; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 11. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 12. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM.
    Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
    [Abstract] [Full Text] [Related]

  • 13. Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.
    Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A.
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):905-10. PubMed ID: 6644314
    [Abstract] [Full Text] [Related]

  • 14. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
    Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA.
    J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
    [Abstract] [Full Text] [Related]

  • 15. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A.
    Alzheimer Dis Assoc Disord; 1989 Mar; 3(3):148-56. PubMed ID: 2477044
    [Abstract] [Full Text] [Related]

  • 16. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R.
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D, Pullar IA, Mawdsley C, Kinloch N, Yates CM.
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
    Mena MA, Aguado EG, de Yebenes JG.
    Acta Neurol Scand; 1984 Apr; 69(4):218-25. PubMed ID: 6204498
    [Abstract] [Full Text] [Related]

  • 19. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H, Lindquist C, Sedvall G.
    Acta Neurochir (Wien); 1985 Apr; 77(3-4):146-51. PubMed ID: 2416192
    [Abstract] [Full Text] [Related]

  • 20. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
    Freed DM, Corkin S, Growdon JH, Nissen MJ.
    Neuropsychologia; 1988 Apr; 26(6):895-902. PubMed ID: 2461537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.